Results for tag: "Vigabatrin"

Vigabatrin is a drug used to treat certain types of epilepsy and other seizure disorders. It is a gamma-aminobutyric acid (GABA) transaminase inhibitor, which works by increasing the amount of GABA in the brain. Vigabatrin is used as an adjunctive therapy for partial seizures, infantile spasms, and refractory complex partial seizures. It is also used to treat refractory status epilepticus. Vigabatrin is a part of the Central Nervous System (CNS) drug market, which includes drugs used to treat neurological disorders such as epilepsy, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. CNS drugs are typically used to treat symptoms of these disorders, such as seizures, tremors, and memory loss. The companies in the Vigabatrin market include Lundbeck, Eisai, and Teva Pharmaceuticals. Lundbeck is a Danish pharmaceutical company that manufactures and markets Vigabatrin under the brand name Sabril. Eisai is a Japanese pharmaceutical company that manufactures and markets Vigabatrin under the brand name Vigabatrin. Teva Pharmaceuticals is an Israeli pharmaceutical company that manufactures and markets Vigabatrin under the brand name Sabril. Show Less Read more